United Therapeutics CEO Martine Rothblatt disposes of 9,595 common shares worth $4.98 million - UTHR News | RalliesUnited Therapeutics CEO Martine Rothblatt disposes of 9,595 common shares worth $4.98 million
U
UTHR• Insider transaction details
- United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at $135.42 on Aug. 5.
- The related trust sold 9,494 shares in multiple trades, with reported prices ranging from $502.29 to $524.59.
- Trust holdings ended the day at 324,443 shares of common stock.
- The trust held 198,910 stock options following the transaction.
•
